pneumonia News
-
Pneumocystis Pneumonia Exposed in New Online Video
Today, the IAQ Video Network and Cochrane & Associates announced the release of another online video to help educate the public about issues that may impact their health. The latest educational video discusses health risks due to Pneumocystis pneumonia and exposure to Pneumocystis jirovecii. Pneumocystis pneumonia, also known as PCP or pneumocystosis is a form of pneumonia that can be ...
-
FRI - Understanding The Link Between Pulmonary Vasculature Abnormalities and DCLO in Covid-19
In a recent article, Prof Daniel Salerno, Prof Victor Kim and colleagues used Functional Respiratory Imaging to better understand the crucial link between DLCO and Pulmonary Vascular Abnormalities in COVID19. COVID-19 is a respiratory viral illness causing pneumonia and systemic disease. Abnormalities in pulmonary function tests infection have been described. The determinants of these ...
By Fluidda
-
Streptococcus pneumoniae Exposed in New Online Video
Today, the IAQ Video Network and Cochrane & Associates announced the release of another online video to help educate the public about issues that may impact their health. The latest educational video discusses Streptococcus pneumoniae infections and how they may impact human health. Streptococcus pneumoniae, or pneumococcus, is a type of Gram-positive bacteria. It can often be found in ...
-
Preventing Outbreaks of Streptococcus pneumoniae Infections
Until 2000, Streptococcus pneumoniae infections caused 100,000-135,000 hospitalizations for pneumonia, 6 million cases of ear infections, and 60,000 cases of invasive disease, including 3300 cases of meningitis. Disease figures have improved since a pneumococcal conjugate vaccine was introduced in 2001. Streptococcus pneumoniae, or pneumococcus, is a type of Gram-positive bacteria. It can ...
-
Wood stove intervention can reduce childhood pneumonia
Cooking stoves with chimneys can lower exposure to indoor wood smoke and reduce the rate of severe pneumonia by 30 percent in children less than 18 months of age, according to a new air pollution study funded by the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health. The study in the Nov. 10 issue of The Lancet showed that rates of severe ...
-
The GRAM paper gives face to the AMR crisis - Vaxdyn’s comment about the GRAM paper
The experts of the Anti-Microbial Resistance (AMR) world, including Vaxdyn’s researchers, have been warning about the entrance into a post-antibiotic era or the occurrence of a silent pandemic for years. However, the general public, including health practitioners, did not understand the message or underscored the magnitude of the problem. Recently, a vast network of AMR experts around the ...
-
Pneumococcal Disease & Streptococcus pneumoniae Discussed in New Video
Today, the IAQ Video Network and Cochrane & Associates announced the release of their latest educational video. Their newest production discusses Streptococcus pneumoniae and pneumococcal disease. “Streptococcus pneumoniae bacteria, sometimes referred to as pneumococcus, is one of the most common causes of severe pneumonia,” said Paul Cochrane, President of Cochrane and ...
-
New respiratory multitest
The new Vitassay SARS-CoV-2 + Flu A + B + RSV + Adeno Resp. is a rapid, immunochromatographic assay for the simultaneous qualitative detection of nucleoprotein antigen of SARS-CoV-2, Influenza type A, Influenza type B, RSV and Adenovirus from nasopharyngeal swabs samples from patients suspected of COVID-19 infection and/or Influenza A and/or Influenza B and/or Respiratory Syncytial Virus (RSV) ...
-
Pune startup launches O2 support device for Covid-19
Pune: Technology startup Nocca Robotics has launched a high flow oxygen therapy (HFOT) device, which has a greater demand than invasive ventilators for treating fairly critical Covid-19 patients. Nocca Robotics has already deployed over 200 ventilators across the country, earning it about Rs 4.4 crore since its launch in July 2020. "We currently have a capacity of manufacturing 500 HFOT devices ...
-
The Intruder - radio soap operas teach local communities about sexual health
Radio Soap Operas Teach Local Communities About Sexual Health By Sarah Grainger, BBC In a modest breeze-block house in a village in Guatemala’s chilly and damp Western highlands, Aura Garcia tunes her small radio every Saturday morning to 93.7FM Radio Arco Iris which broadcasts the soap opera ‘El Intruso’ (the Intruder). Aura is 17-years-old and a member of one of ...
By 3BL Media
-
OpGen Announces Publication of Results from Major Clinical Study Using Unyvero Hospitalized Pneumonia (HPN) Panel in the Lancet Respiratory Medicine
208 patients enrolled in a prospective, randomized, controlled, multicenter, interventional trial Unyvero reduced the use of inappropriate antibiotic therapy by 45%, shortened inappropriate antibiotic therapy by 39 hours, and reduced overall antibiotic therapy duration by 22.5% Unyvero results combined with antibiotic stewardship are efficient and safe in decreasing time on inappropriate ...
By OpGen, Inc.
-
Multidrug-resistant bacteria remain a public health issue in Europe
On the occasion of the European Antibiotic Awareness Day, ECDC is releasing new European-wide surveillance data on antibiotic resistance from the European Antimicrobial Resistance Surveillance Network (EARS-Net). With annually up to 400,000 patients reported to suffer from infections resistant to multiple antibiotics, the data show that antibiotic resistance remains a public health problem across ...
-
Vaxcyte Doses First Participants in Phase 2 Portion of Ongoing VAX-24 Phase 1/2 Clinical Proof-of-Concept Study in Adults
Following Prespecified Review of Phase 1 Safety and Tolerability Data, Independent Data Monitoring Committee Recommends Study Proceed as Planned Company Expects to Announce Topline Results from Both the Phase 1 and Phase 2 Portions of the Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease and Pneumonia by the End of 2022 VAX-24 is a 24-Valent Pneumococcal Conjugate ...
-
Vaxcyte Doses First Participants in Phase 1/2 Clinical Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults
Company Expects to Announce Topline Results from the Phase 1/2 Study by the End of 2022 Proof-of-Concept Study Will Evaluate the Safety, Tolerability and Immunogenicity of VAX-24 VAX-24 is a 24-Valent Pneumococcal Conjugate Vaccine Designed to Deliver Broad-Spectrum Protection Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to ...
-
New Vitassay Rapid Test for SARS-CoV-2 detection
The new Vitassay SARS-CoV-2 is a rapid, immunochromatographic, one step assay for the qualitative detection of SARS-CoV-2 from nasopharyngeal samples. Simple and highly sensitivity immunoassay for professional in vitro use only. SARS-CoV-2 infection can affect individuals of any age. The disease currently causes an overwhelming hospitalization of infected patients, presenting symptoms such as ...
-
Air Pollution Can Alter Effectiveness of Antibiotics
Researchers from the University of Leicester have for the first time discovered that bacteria that cause respiratory infections are directly affected by air pollution - increasing the potential for infection and changing the effectiveness of antibiotic treatment. The interdisciplinary study, which has been published in the journal Environmental Microbiology, has important implications for the ...
By Camfil Ltd
-
CARB-X is funding Spanish biotech Vaxdyn to develop a new vaccine to prevent superbug infections that cause life-threatening pneumonia and other deadly infections
CARB-X is awarding Vaxdyn, based in Seville, Spain, up to US$892,000, plus an additional $6.36 million if certain project milestones are met, to develop a new vaccine to prevent life-threatening drug-resistant infections, including pneumonia. Vaxdyn is the first Spanish biotech to be funded by CARB-X, a non-profit partnership investing $500 million in the development of innovative vaccines, ...
-
Noble Awards $25,000 in Research Services to Synam Vaccine
Noble Awards $25,000 in Research Services to SynAm Vaccine Contributes Drug Development Services through InvestMaryland Business Competition Noble Life Sciences, Inc. (Gaithersburg, MD) awarded $25,000 of its drug development contract research services to SynAm Vaccine (Rockville, MD) as part of the InvestMaryland Challenge business competition. Organized by the state of Maryland, the ...
-
N8 Medical Appoints Infectious Diseases Expert, David S. Perlin, Ph.D., to Scientific Advisory Board
N8 Medical, a clinical-stage biopharmaceutical company focused on developing novel combination medical devices and antifungal and anti-bacterial therapeutics for the prevention and treatment of serious and life-threatening infections, announced today that it appointed David S. Perlin, Ph.D. to its Scientific Advisory Board (SAB). Dr. Perlin is an internationally recognized expert and research ...
-
Yaguo Made the Second Donation
Yaguo Fight against the Epidemic!! Once again Yaguo have made a donation in order to support the frontline of the epidemic, helping with their innovating products that brings out intensive care and rehabilitation. On March 7th, YAGUO sent to Hubei a new set of respiratory devices, the number goes up to 100 devices worth around 2.2 million RMB, including bionic cough simulator (sputum removal ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you